"We are attentive, diligently committed to every detail as we deliver consistently high quality data to our sponsors. We are inventive, embracing a visionary, entrepreneurial spirit that compels us to blaze new trails with proprietary systems and processes. We are Aventiv Research. Aventiv Research is a clinical trial and medical research center. We provide clinical trial opportunities in Dublin for individuals suffering from various chronic diseases, as well as paid clinical trial options for healthy volunteers. We are located just off of Sawmill Rd in Dublin. Contact us today or visit our website for additional information about enrolling in a clinical trial!"

During the past decade, Aventiv Research, Inc. conducted 26 clinical trials. In the 10-year time frame, 26 clinical trials started and 11 clinical trials were completed, i.e. on average, 42.3% percent of trials that started reached the finish line to date. In the past 5 years, 15 clinical trials started and 11 clinical trials were completed. i.e. 73.3% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Aventiv Research, Inc." #1 sponsor was "Pfizer" with 5 trials, followed by "Botanix Pharmaceuticals" with 3 trials sponsored, "Medy-Tox" with 3 trials sponsored, "Eli Lilly and Company" with 2 trials sponsored and "Idorsia Pharmaceuticals Ltd." with 2 trials sponsored. Other sponsors include 6 different institutions and companies that sponsored additional 15 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Aventiv Research, Inc." #1 collaborator was "Iqvia Pty Ltd" with 2 trials as a collaborator, "Athenex, Inc." with 1 trials as a collaborator, "LGC Limited" with 1 trials as a collaborator and "PPD" with 1 trials as a collaborator. Other collaborators include -4 different institutions and companies that were collaborators in the rest 4 trials.

According to Clinical.Site data, the most researched conditions in "Aventiv Research, Inc." are "Glabellar Lines" (4 trials), "Migraine" (4 trials), "Lateral Canthal Lines" (3 trials), "Migraine, With or Without Aura" (3 trials) and "Type 2 Diabetes" (2 trials). Many other conditions were trialed in "Aventiv Research, Inc." in a lesser frequency.

Most popular intervention types in "Aventiv Research, Inc." are "Drug" (24 trials), "Biological" (2 trials) and "Other" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (15 trials), "Rimegepant" (5 trials), "MT10109L" (3 trials), "Vehicle" (3 trials) and "ABP-450" (1 trials). Other intervention names were less common.

The vast majority of trials in "Aventiv Research, Inc." are 25 trials for "All" genders and 1 trials for "Female" genders.

Currently, there are NaN active trials in "Aventiv Research, Inc.". undefined are not yet recruiting, 4 are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 21 completed trials in Aventiv Research, Inc., undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in Aventiv Research, Inc., 0 "Phase 1" clinical trials were conducted, 10 "Phase 2" clinical trials and 16 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 2 trials, and there were also 0 trials that are defined as “Not Applicable".